Resolution of airway inflammation following ovalbumin inhalation comparison of ISS DNA and corticosteroids

American Journal of Respiratory Cell and Molecular Biology

Volumn 28, Issue 6, 2003, Pages 655-663

  Ikeda, Reid K ^a   Nayar, Jyothi ^a   Cho, Jae Youn ^a   Miller, Marina ^a   Rodriguez, Monica ^a   Raz, Eyal ^a   Broide, David H ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CORTICOSTEROID DERIVATIVE; DEXAMETHASONE; GAMMA INTERFERON; IMMUNOSTIMULATING AGENT; IMMUNOSTIMULATORY DNA SEQUENCE; INTERLEUKIN 5; OVALBUMIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; APOPTOSIS; ARTICLE; BRONCHUS HYPERREACTIVITY; CLINICAL PATHWAY; CONTROLLED STUDY; DNA SEQUENCE; DRUG EFFECT; EOSINOPHILIA; EPITHELIUM CELL; FEMALE; IMMUNOSTIMULATION; INFLAMMATION; LUNG ALVEOLUS CELL; LUNG INFECTION; LUNG LAVAGE; MEDIASTINUM LYMPH NODE; MEDICAL ASSESSMENT; MONOTHERAPY; MOUSE; NICK END LABELING; NONHUMAN; PERIODIC ACID SCHIFF STAIN; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; DEXAMETHASONE; DISEASE MODELS, ANIMAL; DNA; DRUG THERAPY, COMBINATION; EOSINOPHILS; FEMALE; INFLAMMATION; INJECTIONS, INTRAPERITONEAL; INTERFERON TYPE II; INTERLEUKIN-5; LYMPH NODES; LYMPHOCYTES; MICE; MICE, INBRED BALB C; OVALBUMIN; PULMONARY EOSINOPHILIA; RESPIRATORY HYPERSENSITIVITY; TREATMENT OUTCOME;

ANIMALIA; BRONCHUS;

EID: 0037783483     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.4853     Document Type: Article

References (31)

1. Sanderson, C. J. 1992. Interleukin-5, eosinophils, and disease. Blood 79:3101-3109.
2. Foster, P. S., S. P. Hogan, A. J. Ramsay, K. I. Matthaei, and I. G. Young. 1996. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183:195-201.
3. Busse, W. W., and R. F. Lemanske, Jr. 2001. Asthma. N. Engl. J. Med. 344:350-362.
4. Broide, D., J. Schwarze, H. Tighe, T. Gifford, M. D. Nguyen, S. Malek, J. V. Uden, E. Martin-Orozco, E. W. Gelfand, and E. Raz. 1998. Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice. J. Immunol. 161:7054-7062.
5. Broide, D. H., G. Stachnick, D. Castaneda, J. Nayar, M. Miller, J. Cho, M. Rodriquez, M. Roman, and E. Raz. 2001. Immunostimulatory DNA mediates inhibition of eosinophilic inflammation and airway hyperreactivity independent of natural killer cells in vivo. J. Allergy Clin. Immunol. 108:759-763.
6. Broide, D. H., G. Stachnick, D. Castaneda, J. Nayar, M. Miller, J. Y. Cho, M. Roman, J. Zubeldia, T. Hyashi, and E. Raz. 2001. Systemic administration of immunostimulatory DNA sequences mediates reversible inhibition of Th2 responses in a mouse model of asthma. J. Clin. Immunol. 21:163-170.
7. Kline, J. N., T. J. Waldschmidt, T. R. Businga, J. E. Lemish, J. V. Weinstock, P. S. Thorne, and A. M. Krieg. 1998. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J. Immunol. 160:2555-2559.
8. Sur, S., J. S. Wild, B. K. Choudhury, N. Sur, R. Alam, and D. M. Klinman. 1999. Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides. J. Immunol. 162:6284-6293.
9. Yamamoto, S., E. Kuramoto, S. Shimada, and T. Tokunaga. 1988. In vitro augmentation of natural killer cell activity and production of interferon-α/β, and γ with deoxyribonucleic acid fraction from Mycobacterium bovis BCG. Jpn. J. Cancer Res. 79:866-873.
10. Yamamoto, T., S. Yamamoto, T. Kataoka, K. Komuro, M. Kohase, and T. Tokunaga. 1994. Synthetic oligonucleotides with certain palindromes stimulate interferon production of human peripheral blood lymphocytes in vitro. Jpn. J. Cancer Res. 85:775-779.
11. Krieg, A. M., A. K. Yi, S. Matson, T. J. Waldschmidt, G. A. Bishop, R. Teasdale, G. A. Koretzky, and D. M. Klinman. 1995. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374:546-549.
12. Klinman, D. M., A. J. Yi, S. L. Beaucage, J. Conover, and A. M. Krieg. 1996. CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6. interleukin 12, and interferon-γ. Proc. Natl. Acad. Sci. USA 93:2879-2883.
13. Sato, Y., M. Roman, H. Tighe, D. Lee, M. Corr, M. D. Nguyen, G. J. Silverman, M. Lotz, D. A. Carson, and E. Raz. 1996. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273:352-354.
14. Roman, M., E. Martin-Orozco, J. S. Goodman, M. D. Nguyen, Y. Sato, A. Ronaghy, R. S. Kornbluth, D. D. Richman, D. A. Carson, and E. Raz. 1997. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat. Med. 3:849-854.
15. Hemmi, H., O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda, and S. Akira. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408:740-745.
16. Chu, W., X. Gong, Z. Li, K. Takabayashi, H. Ouyang, Y. Chen, A. Lois, D. J. Chen, G. C. Li, M. Karin, and E. Raz. 2000. DNA-PKcs is required for activation of innate immunity by immunostimulatory DNA. Cell 103:909-918.
17. Hammelmann, E., J. Schwarze, K Takeda, A. Oshiba, G. L. Larsen, C. G. Irvin, and E. W. Gelfand. 1997. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am. J. Respir Crit. Care Med. 156:766-775.
18. Cho, J. Y., M. Miller. K. J. Baek, D. Castaneda, J. Nayar, M. Roman, E. Raz, and D. H. Broide. 2001. Immunostimulatory DNA sequences inhibit respiratory syncytial viral load, airway inflammation, and mucus secretion. J. Allergy Clin. Immunol. 108:697-702.
19. Clifton, D. R., R. A. Goss, S. K. Sahni, D. van Antwerp, R. B. Baggs, V. J. Marder, D. J. Silverman, and L. A. Sporn. 1998. NF-kappa B-dependent inhibition of apoptosis is essential for host cell survival during Rickettsia rickettsii infection. Proc. Natl. Acad. Sci. USA 95:4646-4651.
20. Webster, M. A., J. N. Hutchinson, M. J. Rauh, S. K. Muthuswamy, M. Anton, C. G. Tortorice, R. D. Cardiff, F. L. Graham, J. A. Hassell, and W. J. Muller. 1998. Requirement for both shc and phosphatidylinositol 3′ kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis. Mol. Cell Biol. 18:2344-2359.
21. Cohn, L., C. Herrick, N. Niu, R. Homer, and K Bottomly. 2001. IL-4 promotes airway eosinophilia by suppressing IFN-gamma production: defining a novel role for IFN-gamma in the regulation of allergic airway inflammation. J. Immunol. 166:2760-2767.
22. Shi, H. Z., A. Humbles, C. Gerard, Z. Jin, and P. F. Weller. 2000. Lymph node trafficking and antigen presentation by endobronchial eosinophils. J. Clin. Invest. 105:945-953.
23. Meagher, L. C., J. M. Cousin, J. R. Seckl, and C. Haslett. 1996. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J. Immunol. 156:4422-4428.
24. Druilhe, A., B. Wallaert, A. Tsicopoulos, J. R. Lapa e Silva, I. Tillie-Leblond, A. B. Tonnel, and M. Pretolani. 1998. Apoptosis, proliferation, and expression of Bcl-2, Fas, and Fas ligand in bronchial biopsies from asthmatics. Am. J. Respir. Cell Mol. Biol. 19:747-757.
25. Woolley, K. L., P. G. Gibson, K. Carty, A. J. Wilson, S. H. Twaddell, and M. J. Woolley. 1996. Eosinophil apoptosis and the resolution of airway inflammation in asthma. Am. J. Respir. Crit. Care Med. 154:237-243.
26. Vignola, A. M, P. Chanez, G. Chiappara, L. Siena, A. Merendino, C. Reina, R Gagliardo, M. Profita, J. Bousquet, and G. Bonsignore. 1999. Evaluation of apoptosis of eosinophils, macrophages, and T lymphocytes in mucosal biopsy specimens of patients with asthma and chronic bronchitis. J. Allergy Clin. Immunol. 103:563-573.
27. Kankaanranta, H., M. A. Lindsay, M. A. Giembycz, X. Zhang, E. Moilanen, and P. J. Barnes. 2000. Delayed eosinophil apoptosis in asthma. J. Allergy Clin. Immunol. 106:77-83.
28. Simon, H. U., S. Yousefi, C. Schranz, A. Schapowal, C. Bachert, and K. Blaser. 1997. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J. Immunol. 158:3902-3908.
29. Tsuyuki, S., C. Bertrand, F. Erard, A. Trifilieff, J. Tsuyuki, M. Wesp, G. P. Anderson, and A. J. Coyle. 1995. Activation of the Fas receptor on lung eosinophils leads to apoptosis and the resolution of eosinophilic inflammation of the airways. J. Clin. Invest. 96:2924-2931.
30. Ohta, K., N. Yamashita, M. Tajima, T. Miyasaka, R. Kawashima, J. Nakano, H. Arioka, A. Ishii, T. Horiuchi, and T. Miyamoto. 2001. In vivo effects of apoptosis in asthma examined by a murine model. Int. Arch. Allergy Immunol. 124:259-261.
31. Serebrisky, D., A. A. Teper, C. K. Huang, S. Y. Lee, T. F. Zhang, B. H. Schofield, M. Kattan, H. A. Sampson, and X. M. Li. 2000. CpG oligodeoxynucleotides can reverse Th2-associated allergic airway responses and alter the B7.1/B7.2 expression in a murine model of asthma. J. Immunol. 165:5906-5912.